Neuralink, Elon Musk’s brain-implant company, announces US FDA approval for clinical trials Read more
US FDA asks Sun Pharma to stop trial on dermatological drug citing potential of blood clots Read more
US FDA accepts Glenmark’s IND application for GRC 54276 to proceed with Phase 1/2 clinical study for treatment of solid tumors and lymphomas Read more